Brachytherapy
Volume 8, Issue 4 , Pages 353-360, October 2009

Critical discussion of different dose–volume parameters for rectum and urethra in prostate brachytherapy

Department of Radiotherapy, Medical University of Vienna, Vienna, Austria

Received 3 September 2008; received in revised form 20 December 2008; accepted 5 January 2009. published online 18 May 2009.

Abstract 

Purpose

To compare different dose–volume histogram (DVH) parameter concepts used for rectum and urethra.

Methods and Materials

Thirty-eight postplan CT scans were used to contour the rectum with only one outer contour and as a wall structure. DVH analysis included dose to absolute and relative volumes of both contour types, from RD0.1cc to RD10cc and from RDmax to RD30, respectively. Volume parameters are reported (RV50–RV300) in cubic centimeters and percentages. The analysis of urethral dose parameters was based on 55 CTs with a urethral catheter. Relative (UD100 to UDmax) and absolute volume parameters (UD0.5cc to UD0.1cc, UV100, UV150) were evaluated, and also correlated to prostate parameters. The analysis was repeated for 10 MRI-based interstitial high-dose rate cases.

Results

The correlation between organ and wall results was high for RD1, RD2cc, and RD0.1cc, with differences of <5%. DVH parameters reporting dose to a relative volume (e.g., RD10) or a relative volume related to a certain dose (e.g., RV100 [%]) are sensitive to the number of contoured slices. Dmax has a high uncertainty due to the sampling algorithm. RV100 (145Gy) of 1.5cc is similar to an RD2cc of 130Gy.

The urethral UD10 and UD0.1cc correlate with a mean difference of 1%. The ratios of UD5/UD30, UD10/UD30, and UD5/UD10 were 1.12, 1.09, and 1.03, respectively. The correlation between D90 and D10 for prostate to urethra UD10 was poor.

Conclusions

Only absolute volume parameters are stable in relation to different contouring concepts. When delineating the outer rectum contour, only RD2cc and RD0.1cc can be used. RV100 in cc correlates to RD2cc. Reporting UD5, UD10, and UD30 together is redundant. Additional information is given when reporting UV100 or UV150.

Keywords: Brachytherapy, Prostate cancer, Treatment planning, DVH parameters, Dosimetry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1538-4721(09)00198-6

doi:10.1016/j.brachy.2009.01.003

Brachytherapy
Volume 8, Issue 4 , Pages 353-360, October 2009